Cystatins C, E/M and F in Human Pleural Fluidsof Patients with Neoplastic and InflammatoryLung Disorders

Verfasser / Beitragende:
[B. Werle, K. Sauckel, C.-M. Nathanson, M. Bjarnadottir, E. Spiess, W. Ebert, M. Abrahamson]
Ort, Verlag, Jahr:
2003
Enthalten in:
Biological Chemistry, 384/2(2003-02-20), 281-287
Format:
Artikel (online)
ID: 378874314
LEADER caa a22 4500
001 378874314
003 CHVBK
005 20180305123417.0
007 cr unu---uuuuu
008 161128e20030220xx s 000 0 eng
024 7 0 |a 10.1515/BC.2003.031  |2 doi 
035 |a (NATIONALLICENCE)gruyter-10.1515/BC.2003.031 
245 0 0 |a Cystatins C, E/M and F in Human Pleural Fluidsof Patients with Neoplastic and InflammatoryLung Disorders  |h [Elektronische Daten]  |c [B. Werle, K. Sauckel, C.-M. Nathanson, M. Bjarnadottir, E. Spiess, W. Ebert, M. Abrahamson] 
520 3 |a Secretory type 2 cystatins, like cystatins C, E/M and F, are thought to be involved in many pathobiological processes, including vascular amyloidosis, rheumatoid arthritis, Alzheimers disease, osteoporosis, viral and bacterial infections, inflammatory disorders and tumour invasion and metastasis. In order to define the levels of cystatins C, E/M, and F in pleural effusions and to investigate whether these cystatins correlate with diagnostic parameters of pleural and lung diseases, we determined their concentrations in 160 pleural effusions. The median concentration of cystatin C in pleural effusions was 1437 ug/l (95.8 nM), ranging between 18-3967 ug/l. Cystatin C did neither correlate with malignant nor with benign diseases. The concentration of cystatin E/M was significantly higher in effusions of primary pleural tumours (mesotheliomas) compared to secondary pleural tumours and benign diseases. Furthermore, there was a significant correlation between the concentration of cystatin E/M of mesotheliomas and the pleural fluid tumour cell count and of cystatin C. The median values of cystatin F were significantly increased in parapneumonic/ empyema thoracis pleural effusions and tuberculous pleurisy compared to malignant pleural effusions, respectively. The concentration of cystatin F in benign effusions correlated significantly with diagnostic parameters and inflammation (total protein; lactate dehydrogenase; C-reactive protein). Finally, only in the group of parapneumonic/empyema thoracis was there a significant correlation between cystatin F and the neutrophil count. In conclusion, pleural effusions of different origin contain high levels of cystatin C, perhaps constituting the major part of an inhibitor reservoir. The level of cystatin E/M appears to be significantly associated with primary pleural tumours and cystatin F correlates with inflammatory processes of lung disorders. 
540 |a Copyright © 2003 by Walter de Gruyter GmbH & Co. KG 
690 7 |a Biochemistry  |2 nationallicence 
690 7 |a Molecular biology  |2 nationallicence 
690 7 |a Cellular biology  |2 nationallicence 
700 1 |a Werle  |D B.  |4 aut 
700 1 |a Sauckel  |D K.  |4 aut 
700 1 |a Nathanson  |D C.-M  |4 aut 
700 1 |a Bjarnadottir  |D M.  |4 aut 
700 1 |a Spiess  |D E.  |4 aut 
700 1 |a Ebert  |D W.  |4 aut 
700 1 |a Abrahamson  |D M.  |4 aut 
773 0 |t Biological Chemistry  |d Walter de Gruyter  |g 384/2(2003-02-20), 281-287  |x 1431-6730  |q 384:2<281  |1 2003  |2 384  |o bchm 
856 4 0 |u https://doi.org/10.1515/BC.2003.031  |q text/html  |z Onlinezugriff via DOI 
908 |D 1  |a research article  |2 jats 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1515/BC.2003.031  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Werle  |D B.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Sauckel  |D K.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Nathanson  |D C.-M  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Bjarnadottir  |D M.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Spiess  |D E.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Ebert  |D W.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Abrahamson  |D M.  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Biological Chemistry  |d Walter de Gruyter  |g 384/2(2003-02-20), 281-287  |x 1431-6730  |q 384:2<281  |1 2003  |2 384  |o bchm 
900 7 |b CC0  |u http://creativecommons.org/publicdomain/zero/1.0  |2 nationallicence 
898 |a BK010053  |b XK010053  |c XK010000 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-gruyter